Corcept Therapeutics Incorporated shares owned by Ing Investment Management
Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Ing Investment Management
from 13F filings
Historical chart of Ing Investment Management investment in Corcept Therapeutics Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Corcept Therapeutics Incorporated held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Corcept Therapeutics Incorporated by Ing Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $881k | 32k | 27.25 |
| 2023-06-30 | $5.5M | 247k | 22.25 |
| 2023-03-31 | $7.1M | 327k | 21.66 |
| 2022-12-31 | $2.4M | 116k | 20.31 |
| 2022-09-30 | $3.0M | 115k | 25.64 |
| 2022-06-30 | $5.7M | 238k | 23.78 |
| 2022-03-31 | $832k | 36k | 22.93 |
| 2021-12-31 | $743k | 38k | 19.79 |
| 2021-09-30 | $755k | 38k | 19.68 |
| 2021-06-30 | $869k | 40k | 22.00 |
| 2021-03-31 | $1.2M | 52k | 23.78 |
| 2020-12-31 | $1.4M | 53k | 26.16 |
| 2020-09-30 | $965k | 55k | 17.41 |
| 2020-06-30 | $940k | 56k | 16.82 |
| 2020-03-31 | $837k | 70k | 11.89 |
| 2019-12-31 | $837k | 69k | 12.10 |
| 2019-09-30 | $878k | 62k | 14.14 |
| 2019-06-30 | $694k | 62k | 11.14 |
| 2019-03-31 | $746k | 64k | 11.74 |
| 2018-12-31 | $874k | 65k | 13.36 |
| 2018-09-30 | $1.0M | 72k | 14.02 |
| 2018-06-30 | $1.1M | 72k | 15.72 |
| 2018-03-31 | $1.2M | 73k | 16.45 |
| 2017-12-31 | $1.3M | 75k | 18.06 |
| 2017-09-30 | $803k | 42k | 19.30 |
| 2017-06-30 | $491k | 42k | 11.80 |
| 2017-03-31 | $312k | 29k | 10.97 |
| 2016-12-31 | $207k | 29k | 7.28 |
| 2016-09-30 | $185k | 29k | 6.50 |
| 2016-06-30 | $155k | 29k | 5.45 |
| 2016-03-31 | $133k | 29k | 4.67 |
| 2015-12-31 | $142k | 29k | 4.99 |
| 2015-09-30 | $107k | 29k | 3.76 |
| 2015-06-30 | $171k | 29k | 6.01 |
Top funds holding Corcept Therapeutics Incorporated
View all funds holding Corcept Therapeutics Incorporated